drugset / Trial / NCT05984550
The Exploratory Study on the Nicotinamide Mononucleotide (Vital NAD ) to Promote the Rejuvenation of the Peripheral Blood Immune Cells of Adults.
Phase 0
Unknown
10 enrolled
Shanghai Cell Therapy Group Co.,Ltd
Shanghai Mengchao Cancer Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to investigate the changes in adult peripheral blood immune cell subpopulations, subpopulations, and cell functional status before and after intervention with Nicotinamide Mononucleotide (Vital NAD ) as NAD+ supplement for a certain period of time。To Explore and validate the biological functions of Nicotinamide Mononucleotide (Vital NAD ) of rejuvenation of the Peripheral blood immune cells of Adults.
Timeline
- Start
- 2023-08
- Primary completion
- 2024-03
- Completion
- 2024-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nicotinamide Mononucleotide | Unknown | 600 mg | — |
Indications
No indication recorded.